CYP21A2 and polycystic ovary syndrome: We found that although no pathogenic mutation of CYP21A2 was observed, the frequency of CYP21A2 c.552 C > G (p. D184E) was significantly higher in the lean PCOS patients compared with the obese PCOS patients.